Adenovirus

Fierce Biotech

Sarepta faces new scrutiny after 3rd patient death

Analysts grilled Sarepta on Friday for failing to disclose a third gene therapy patient death prior to a restructuring announcement earlier this week.

Fraiser Kansteiner Jul 18, 2025 10:19am